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The demonstration that 4-ethylsulphonylnaphthalene-1-sulphonamide (HPA)
induces hyperplasia of the bladder epithelium in the rat and the mouse (Paget,
1958; Sen Gupta, 1962a) suggested that the chemical might act either as a co-
carcinogen or as a promoting agent to this tissue. Such properties would be
valuable in designing experiments to elucidate the mechanism of induction of
bladder tumours and, accordingly, two series ofexperiments were started.
Bonser and Clayson (1964) showed that HPA was carcinogenic to the bladder
epithelium of hybrid Ab x IF mice when it was incorporated at a level of 0-01
per cent in the diet for up to 65 weeks. Females were more susceptible than
males. The incidence of tumours was not increased by the administration of a
single oral dose of 2-5 mg. 9,10-dimethyl-1,2-benzanthracene (DMBA) one week
before the start oftreatment with HPA.
Sen Gupta (1962b) implanted paraffin wax pellets containing 2-amino-l-
naphthol hydrochloride into the lumen of the bladder of stock mice, and found
that the oral administration of HPA considerably augmented the incidence of
tumours. Unfortunately he did not determine the influence of HPA on the
tumour yield in mice implanted with unadulterated paraffin wax pellets. There-
fore it is not possible to decide, on the basis ofthis experiment alone, whether the
HPA acted as a cocarcinogen orwhether it was a more potent complete carcinogen
when it acted on the bladders ofmice containing a foreign body, i.e. the pellet.
In this report further evidence is given on the possible promoting or cocarcino-
genic actions of HPA.
MATERIALS AND METHODS
Fl hybrid mice of strains C57 and IF, and Ab and IF were bred in the lab-
oratory. They received Oxo Diet 41B and water ad libitum, and were used for
experiment when they were approximately 10 weeks of age.
Bladder implantation was carried out in female C57 x IF mice by the method
ofJull (1951) as modified by Allen, Boyland, Dukes, Horning and Watson (1957).
Bladders were prepared for histology as described by Sen Gupta (1962a).
4-Ethylsulphonylnaphthalene-l-sulphonamide (HPA) was prepared from
naphthionic acid by the method of Brimelow and Vasey (1958). Chromato-
graphically purified l-phenylazo-2-naphthol and crushed paraffin wax were
obtained from the British Drug Houses Ltd., and 2-acetamidofluorene (AAF)
and 9,10-dimethyl-1,2-benzanthracene (DMBA) from L. Light & Co. Ltd.D. B. CLAYSON AND G. M. BONSER
TABLE I.-Ab x IF Mice Treated with HPA (0.01 per cent of Diet) With and Without Other
Chemicals
Bladder lesions
Number of mice dying within Squa-
stated period (weeks) mous Carcinomat
]Experi- ,- Hepa- Hyper- meta- Papil-,
ment Treatment: Sex 30-39 40-49 50-59 60-69* Total tomas plasia plasia lomat I II III Total
1§. HPA only ... 2) 4 1 9 16 .0 11 4 1 1 1 0 2
2§. HPA only F.. 2 4 3 10 19 .0 . 11 8 1 6 3 0 9
3§. DMBA+ HPA. M.. 0 6 4 7 17 .0 10 3 0 3 1 0 4
4§. DMBA-+HPA. F.. 1 4 6 7 18. 0 14 6 4 4 0 1 5
5 HPA only M. 0 0 6 12 18 0 . 17 0 1 2 1 0 3
6. HPA only F.. 0 0 1 19 20 .0 14 4 2 5 3 1 9
7 .AAF + HPA M.. 0 0 0 9 9. 0 5 1 0 0 0 0 0
8 .AAF + HPA F.. 0 1 1 16 18 .0 14 5 5 3 3 0 6
9 .AAF only .M.. 0 0 3 16 19 .6 2 0 0 0 0 0 0
10 .AAF only .F.. 0 0 0 14 14 .1 0 0 0 0 0 0
* all surviving mice were killed at 65 weeks except 4 in experiment 1, which were killed at 69 weeks.
t only the most advanced lesion is recorded.
I for details see text.
§ Bonser and Clayson (1964).
Probabilities were evaluated by the exact method for 2 x 2 tables (Fisher,
1950).
RESULTS
The oral administration of HPA to Ab x IF mice
ExDeriments 1-4 (Table I) are those described by Bonser and Clayson (1964).
A small number of mice have been added to those originally recorded and two
which failed to live for 30 weeks have been excluded. When HPA was admini-
stered at a level of 0-01 per cent in the diet (experiments 1, 2), 9 out of 19 female
and 2 out of 16 male Ab x IF mice developed carcinomas, 7 Grade I (that is to
say, histologically malignant but not invading muscle) and 4 Grade II (into
muscle). There is a significant difference in carcinoma incidence between the
sexes (P 0.015). The administration of a single dose of 2.5 mg. DMBA one
week before the start of treatment with HPA (experiments, 3, 4) diminished the
yield of carcinomas in female mice but had little effect on the combined incidence
of papillomas and carcinomas. Whereas the combined tumour incidence was in
favour of the females, the carcinomas were fairly evenly divided between the
sexes.
It was decided to try to confirm the sex differences in the incidence of carcino-
mas induced by HPA alone and to determine whether another form of pretreat-
ment would augment the yield oftumours. AAF was chosen for the pretreatment
because, unlike systemically administered DMBA, it is known to be carcinogenic
to the mouse bladder (Armstrong and Bonser, 1947 ; Foulds, 1947). Three
groups of male and three of female Ab x IF mice (experiments 5-10) were set up.
One group of male and one of female mice were given 0*01 per cent of HPA for
the duration of the experiment. The remainder were given 0*03 per cent AAF in
the diet for 4 weeks only and one group of males and one of females were sub-
sequently left untreated while the others were transferred to the HPA diet.
The carcinogenic activity of HPA to the bladder epithelium was confirmed.
There were 3 carcinomas in 18 male and 9 carcinomas in 20 female mice. Seven
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of these were Grade I, 4 were Grade II and one was Grade III (that is to say, had
spread through the bladder wall). The female was again more susceptible than
the male although the difference did not attain statistical significance (P 0-061).
The overall incidence of bladder tumours in female Ab x IF mice treated with
HPA in the diet was 46 per cent (18 carcinomas in 39 mice) and in males was 15
per cent (5 carcinomas in 34 mice). This difference is statistically significant
(P 0.0037).
Pretreatment with AAF reduced rather than augmented the yield of carci-
nomas. No carcinomas were found in 9 male, and 6 carcinomas in 20 female
mice which had received both AAF and HPA (P = 0.063). In addition 5 female
mice had papillomas but no carcinomas. Therefore it appears that the admini-
stration of DMBA or AAF reduces the induction of frank carcinomas in female
mice by HPA. The effect in male mice is not clear because of the small number
of tumours.
In only 3 of 33 mice treated with AAF for one month, and then left for the
duration of the experiment, was hyperplasia of the bladder present. No other
bladder lesions were found. In 6 of 19 male and one of 14 female mice treated in
this way there were hepatomas. Similar tumours occur spontaneously inAb x IF
mice more than 80 weeks ofage (Clayson, Lawson, Santana and Bonser, 1965), the
incidence being 40 per cent in males and 14 per cent in females. The limited dose
of AAF may have reduced the latent period of these tumours to a certain extent.
Because the number of male mice surviving treatment with AAF and HPA was
small (experiment 7) it is not possible to be categorical about the inhibition of the
liver tumours by HPA. However, fatty degeneration and centrilobular necrosis
were found in about one quarter of all the mice treated with AAF alone and were
not observed in those mice treated with AAF and HPA. Therefore we consider
that the liver lesions may have been inhibited by HPA in the doubly treated mice.
The effect of oral HPA on C57 x IF mice with pellets in the bladder
Sen Gupta (1962b) showed that orally administered HPA increased the
incidence of tumours induced by the implantation of pellets containing 2-amino-
1-naphthol hydrochloride into the lumen of the bladder of stock mice. In the
present series of experiments it was decided to use a more stable carcinogen,
1-phenylazo-2-naphthol, in place of the labile 2-amino-1-naphthol hydrochloride.
Approximately 200 female C57 x IF mice were implanted with 15-17 mg.
pellets of crushed paraffin wax and a further 200 with similar pellets containing
12X5 per cent ofthe azo compound. Half ofthe mice in each group were given no
further treatment (experiments 11, 13) and, after 2 weeks had elapsed to allow the
effects of the operation to subside, the remainder were given a diet containing
0X005 per cent HPA (experiments 12, 14). AU surviving mice were killed 40 weeks
after the operation.
Carcinomas were found in all four groups ofmice (Table II). The incidence in
mice implanted with paraffin wax only was 4X5 per cent (4 carcinomas in 89 mice)
which was raised to 19 per cent (14 carcinomas in 75 mice) by the oral administra-
tion of HPA. Pellets containing I-phenylazo-2-naphthol induced a 14 per cent
incidence of tumours (14 carcinomas in 100 mice) and this was increased sub-
stantially by HPA to 73 per cent (44 carcinomas in 60 mice). The incidence of
tumours induced by I-phenylazo-2-naphthol alone was considerably lower than
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TABLEII.-The Influence of Orally Administered HPA on the Incidence of Epithelial Tumours
in C57 x IF Mice Implanted with Pellets in the Bladder
Oral administra- Number of
tion of mice sur- Squamous Carcinomas
Experi- Nature of HPA (0005 viving 25 meta- Papillomas A
ment pellets per cent) weeks plasia or adenomas I II III Total Per cent
11 . Paraffin wax . 89 . 0 . 0 . 3 1 0 4 4.5
12 . Parafflnwax . + . 75 . 14 2 11 3 0 14 18-7
13 .1-Phenylazo-. . 100 . 2 . 0 .9 5 0 14 14-0
2-naphthol
14 . I-Phenylazo- . + . 60 . 16 . 0 . 25 19 0 44 73- 3
2-naphthol
TABLE III.-The Carcinogenic Activity of HPA After Bladder Implantation in C57 x IF Mice
Number of
mice sur- Squamous Carcinomas
Experi- Nature of viving 25 meta- Papillomas
ment pellets weeks plasia or adenomas I II III Total Per cent Probability
11 .Paraffin wax . 89 . 0 . 0 .3 1 0 4 4-5
only
15 .HPA in wax . 37 0 . 1 .6 2 0 8 21-6 0-0056
the 25 per cent obtained in a previous experiment (Bonser, Bradshaw, Clayson
and Jull, 1956).
The bladder epithelium of mice treated with HPA showed a greater tendency
to squamous metaplasia than that of those which only had pellets in the bladder.
The carcinomas, however, were all of Grade I or Grade II and no trend to greater
malignancy with increasing tumour yield was apparent.
The bladder implantation of HPA
Although the induction of bladder tumours following the systemic administra-
tion of an otherwise innocuous chemical has previously been taken to indicate
that the chemical is active by virtue of a metabolic conversion, it was decided to
investigate HPA for local carcinogenic activity by bladder implantation. It was
found (Table III) that HPA in a 12-5 per cent suspension in crushed paraffin wax
induced 22 per cent of carcinomas (8 tumours in 37 mice) compared to a 4.5 per
cent incidence in the controls. It is thus locally active to the bladder epithelium
of the mouse (P = 0.0056).
DISCUSSION
4-Ethylsulphonylnaphthalene-l-sulphonamide (HPA) does not appear to be
related to any of the known groups of chemical carcinogens. One other sul-
phonamide has been reported in the literature to induce carcinomas ofthe bladder
in the rat (Hueper, 1962). The investigations ofHPA have, so far, shown that it
induces cancer of the bladder epithelium in hybrid Ab x IF mice following
systemic administration. Its long term effects in other mice and in other species
remain to be examined.
The greater susceptibility of the female Ab x IF mouse to the induction of
bladder cancer by HPA, compared with the male, may have one of the two
following explanations. It is possible that mouse bladder epithelium is under
direct hormonal control and, when the correct carcinogenic stimulus is applied,
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in the female it progresses more easily to malignancy. However, Armstrong and
Bonser (1947) found that in the RIJI, IF and White Label strains the male mouse
was slightly more susceptible to the induction of bladder tumours by AAF than
was the female. Foulds (1947) who treated RIII mice with the same carcinogen
for a shorter period, showed that the male mice developed bladder cancer in 12
out of 23 cases whereas none of the 13 females did so. Therefore, if hormones are
thought to influence directly the genesis ofbladder tumours, the male environment
must favour the induction of tumours by AAF and the female environment those
induced by HPA.
The second possible reason for the sex differences in the incidence of bladder
cancer is that the hormonal environment affects the metabolism ofthese chemicals
and that the female excretes more of the locally active metabolite of HPA into
the urine whereas the male excretes more ofthat ofAAF. Weisburger, Grantham
and Weisburger (1964) examined the metabolism of the suspected locally active
metabolite of AAF, N-hydroxy-2-acetamidofluorene, in Fischer rats and found
that the female excreted considerably more of this compound in the urine than
did the male. Intraperitoneal injection of AAF itself into male and female ACI
rats showed similar but less marked differences in the pattern of metabolites
(Weisburger and Weisburger, 1963). Further studies along these lines are needed.
The considerable incidence of bladder carcinomas obtained after the oral
administration of HPA indicates that it is a complete carcinogen and not solely a
promoting agent, which should ideally induce cancers only after the application of
an initiating agent. The fact that the prior oral administration of two potent
carcinogens, AAF and DMBA, did not increase the tumour yield supports the view
that HPA is a complete carcinogen. The diminution in incidence ofcarcinomas in
females following the application of AAF or DMBA is possibly due to the effect of
these chemicals on the metabolism of HPA.
Sen Gupta's (1962b) observation that oral HPA increases the incidence of
tumours induced by pellets implanted into the bladder has been confirmed.
Oral HPA increases the tumour yield with paraffin wax pellets from 4-5 to 19 per
cent and with pellets containing I-phenylazo-2-naphthol from 14 to 73 per cent.
It is interesting, although it may be coincidental, that the ratios of the tumour
incidences with and without HPA are similar for the paraffin wax pellets (4.2)
and for those containing I-phenylazo-2-naphthol (5.2).
Relatively little is known about the mechanism of induction of either hyper-
plasia or carcinoma of the bladder by HPA. By analogy with the aromatic
amines (Clayson, 1964) it was suspected that HPA would be effective by virtue of
its conversion to an active metabolite excreted by way of the urine (Santana,
1963). However, it has been found that HPA itself is locally active to the
bladder epithelium when tested by bladder implantation. Therefore if, as seems
plausible from the attempts to account for the results of the other experiments,
the carcinogenic activity of HPA depends on its metabolism, it follows that
either HPA must be converted in vivo to a more active substance or that it is
metabolised to an easily excretable form which is re-converted in the urinary
tract or its epithelium to HPA itself.
SUMMARY
1. 4-Ethylsulphonylnaphthalene-l-sulphonamide is carcinogenic to the bladder
epithelium of the Ab x IF mouse after oral administration. The incidence of
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tumours in female mice (46 per cent) was greater than in male mice (15 per cent).
2. The administration of 9,10-dimethyl-1,2-benzanthracene or 2-acetamido-
fluorene before 4-ethylsulphonylnaphthalene-1-sulphonamide depressed the inci-
dence of carcinomas in female mice but had little effect in the male.
3. Oral 4-ethylsulphonylnaphthalene-1-sulphonamide increased the incidence
of carcinomas induced by the bladder implantation of plain paraffin wax pellets
or those containing I-phenylazo-2-naphthol four- to five-fold.
4. 4-Ethylsulphonylnaphthalene-1-sulphonamide wasincorporatedintoparaffin
wax pellets and implanted in the lumen of the mouse bladder. The incidence
of carcinomas was significantly increased over that induced by paraffin wax
alone. It is judged to be a locally active carcinogen to the bladder epithelium.
5. These results are discussed in the light of the possible promoting and
cocarcinogenic properties of the chemical. It is suggested that variation in the
metabolism ofthe compound may offer the best explanation ofthe results.
We thank Mrs. Doris Khan and Miss Margery Wood, B.Sc., for operating upon
and caring for the bladder implanted mice.
REFERENCES
ALLEN, M. J., BOYLAND, E., DUKES, C. E., HORNING, E. S. AND WATSON, J. G.-(1957)
Brit. J. Cancer, 11, 212.
ARMSTRONG, E. C. AND BONSER, G. M.-(1947) J. Path. Bact., 59, 19.
BONSER, G. M., BRADSHAW, L., CLAYSON, D. B. AND JULL, J. W.-(1956) Brit. J.
Cancer, 10, 539.
Idem AND CLAYSON, D. B.-(1964) Brit. J. Urol., 36, 26.
BRIMELOW, H. C. AND VASEY, C. H.-(1958) U.K. Patent No. 791, 529.
CLAYSON, D. B.-(1964) Brit. med. Bull., 20, 115.
Idem, LAWSON, T. A., SANTANA, S. AND BONSER, G. M.-(1965) Brit. J. Cancer, 19, 297.
FISHER, R. A.-(1950) 'Statistical Methods for Research Workers'. 11th Edition.
Edcinburgh (Oliver and Boyd).
FOULDS, L.-(1947) Brit. J. Cancer, 1, 172.
HUEPER, W. C.-(1962) Clin. Pharmacol. Ther., 3, 776.
JULL, J. W.-(1951) Brit. J. Cancer, 5, 328.
Paget, G. E.-(1958) 'A Symposium on the Evaluation of Drug Toxicity'. Edited by
A. L. Walpole and A. Spinks. London (J. & A. Churchill).
SANTANA, S.-(1963) Brit. J. Cancer, 17, 715.
SEN GUPTA, K. P.-(1962a) Ibid., 16, 110.-(1962b) Nature, Lond., 194, 1185.
WEISBURGER, E. K., GRANTHAM, P. H. AND WEISBURGER, J. H.-(1964) Biochemistry,
3, 808.
WTEISBURGER, J. H. AND WEiSBURGER, E. K.-(1963) Acta Un. int. Cancr., 19, 513.